Latest Distributions News

De.mem Limited has extended its growth streak with record quarterly cash receipts of approximately $10.4 million, a 31% increase year-on-year, alongside positive operating cash flow of $504,000 for the March 2026 quarter.

Felix Group Holdings reported a 47% surge in total ARR to $12.7 million in Q3 FY26, driven by the Nexvia acquisition and enterprise expansion. The company is progressing AI platform enhancements and completed a key leadership renewal with new Chairman and CEO appointments.

Cycliq Group’s Q3 FY2026 customer receipts fell 23% year-on-year to $561k, though a late March UpRide Birthday campaign injected $256k in revenue. Operating cash outflows reflect prior quarter cost settlements, with hopes for cost normalisation and sales momentum in Q4.

N1 Holdings delivered record settlement volumes and a 127% surge in quarterly cash receipts despite challenging market conditions, driven by disciplined funding and operational efficiency.

Wide Open Agriculture appoints Craig Swan as CEO and pivots to a contract manufacturing model to improve economics and scale lupin protein production, while receiving a A$1.69 million R&D tax rebate.

Dicker Data has formally appointed Fiona Brown as Managing Director while introducing deferred short-term incentives for senior executives, aligning pay with long-term growth and governance standards.

Phoslock Environmental Technologies reported a stable sales volume and improved cash flow compared to last year, while ramping up production after reopening its Chinese factory. The company is advancing R&D on a new lanthanum product and faces ongoing legal challenges with mediation set for June.

Arika Resources has reported a fresh wave of thick, high-grade gold intercepts at its Yundamindra Gold Project in Western Australia, reinforcing the project's potential ahead of a maiden resource estimate.

8common Limited reported a 7% rise in SaaS revenue to $1.2 million in Q3 FY26, backed by fresh government contracts and cost cuts. The fintech is on track to deliver full year EBITDA positive and maintain solid operational cash flow.

First Graphene has demonstrated a significant carbon reduction in cement roof tiles through a UK production trial with FP McCann, using graphene-enhanced cement to lower emissions and material use.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

XRF Scientific is set to broaden its industrial reach by acquiring Bruker’s Combustion Gas Analysis business for USD 4 million, adding a profitable product line and new market sectors.